Alvaro Sierra

Valladolid, CL, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Patient satisfaction with calcitonin gene-related peptide monoclonal antibodies in migraine: A multicenter prospective cohort study.

Patient satisfaction with calcitonin gene-related peptide monoclonal antibodies in migraine: A multicenter prospective cohort study.

Journal: Headache

Published: June 10, 2024

Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study.

Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study.

Journal: European journal of neurology

Published: August 30, 2023

Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study.

Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study.

Journal: Pain medicine (Malden, Mass.)

Published: August 02, 2023

Real-World Evaluation of the Tolerability to Onabotulinum Toxin A: The RETO Study.

Real-World Evaluation of the Tolerability to Onabotulinum Toxin A: The RETO Study.

Journal: Toxins

Published: November 13, 2022

Machine-learning-based approach for predicting response to anti-calcitonin gene-related peptide (CGRP) receptor or ligand antibody treatment in patients with migraine: A multicenter Spanish study.

Machine-learning-based approach for predicting response to anti-calcitonin gene-related peptide (CGRP) receptor or ligand antibody treatment in patients with migraine: A multicenter Spanish study.

Journal: European journal of neurology

Published: May 25, 2022

Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors.

Amitriptyline for post-COVID headache: effectiveness, tolerability, and response predictors.

Journal: Journal of neurology

Published: March 30, 2022

Daily Headache in Chronic Migraine Is a Predictive Factor of Response in Patients Who Had Completed Three Sessions of OnabotulinumtoxinA.

Daily Headache in Chronic Migraine Is a Predictive Factor of Response in Patients Who Had Completed Three Sessions of OnabotulinumtoxinA.

Journal: Toxins

Published: April 29, 2021

Frequency and phenotype of headache in covid-19: a study of 2194 patients.

Frequency and phenotype of headache in covid-19: a study of 2194 patients.

Journal: Scientific reports

Published: April 14, 2021

Linear Headache: A Novel Entity or a Variant of Nummular Headache? Clinical Characteristics and Treatment Response in a Series of 16 Patients.

Linear Headache: A Novel Entity or a Variant of Nummular Headache? Clinical Characteristics and Treatment Response in a Series of 16 Patients.

Journal: Pain medicine (Malden, Mass.)

Published: March 16, 2021

Chronic migraine with daily headache. Literature review

Chronic migraine with daily headache. Literature review

Journal: Revista de neurologia

Published: February 11, 2021

Patients and general practitioners assessment of the main outcomes employed in the acute and preventive treatment of migraine: a cross sectional study.

Patients and general practitioners assessment of the main outcomes employed in the acute and preventive treatment of migraine: a cross sectional study.

Journal: BMC neurology

Published: February 03, 2021

Triptanophobia in migraine: A case-control study on the causes and consequences of the nonuse of triptans in chronic migraine patients.

Triptanophobia in migraine: A case-control study on the causes and consequences of the nonuse of triptans in chronic migraine patients.

Journal: Expert review of neurotherapeutics

Published: October 28, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026